Legal & General Group PLC Syros Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.78 - $8.9 $3,582 - $40,877	-4,593 Closed	0 $0
Q2 2022 Aug 22, 2022	SELL	$0.69 - $1.21 $507 - $889	-735 Reduced 13.8%	4,593 $4,000
Q2 2021 Aug 12, 2021	BUY	$5.01 - $7.48 $901 - $1,346	180 Added 3.5%	5,328 $29,000
Q1 2021 May 17, 2021	SELL	$7.19 - $14.95 $88,127 - $183,242	-12,257 Reduced 70.42%	5,148 $39,000
Q4 2020 Feb 12, 2021	BUY	$6.66 - $14.66 $81,691 - $179,819	12,266 Added 238.68%	17,405 $189,000
Q3 2020 Nov 13, 2020	SELL	$8.69 - $14.47 $14,816 - $24,671	-1,705 Reduced 24.91%	5,139 $45,000
Q2 2020 Aug 14, 2020	BUY	$5.21 - $11.03 $5,892 - $12,474	1,131 Added 19.8%	6,844 $73,000
Q1 2020 May 14, 2020	SELL	$4.46 - $9.2 $6,444 - $13,293	-1,445 Reduced 20.19%	5,713 $31,000
Q4 2019 Feb 13, 2020	BUY	$4.52 - $10.1 $6,178 - $13,806	1,367 Added 23.61%	7,158 $49,000
Q2 2019 Aug 14, 2019	BUY	$5.5 - $9.75 $7,540 - $13,367	1,371 Added 31.02%	5,791 $46,000
Q1 2019 May 15, 2019	BUY	$5.51 - $9.59 $4,270 - $7,432	775 Added 21.26%	4,420 $40,000
Q2 2018 Aug 10, 2018	BUY	$10.16 - $13.65 $10,881 - $14,619	1,071 Added 41.61%	3,645 $37,000
Q1 2018 May 17, 2018	SELL	$9.47 - $12.98 $9,754 - $13,369	-1,030 Reduced 28.58%	2,574 $33,000
Q4 2017 Feb 13, 2018	BUY	$8.45 - $17.48 $30,453 - $62,997	3,604	3,604 $35,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.